Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
No Image Available

Gefitinib 250 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 250 mg

Reference Brands: Iressa (US/EU)

Category: Oncology Cancer Care

Gefitinib is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Gefitinib — third party manufacturing & bulk supply

Gefitinib 250 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Gefitinib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Gefitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Gefitinib →
Back to Listing

Frequently Asked Questions

Gefitinib is listed as Tablets in 250 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Gefitinib is referenced against Iressa (US/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Gemcitabine

Strength:
200mg / 1 g / 1.4g

Form: Injection

Reference Brands: Gemzar (US/EU)

View Details
Gemcitabine

Strength:
200 / 1000 mg

Form: Injection

Reference Brands: Gemzar (US/EU)

View Details
Fludarabine Phosphate

Strength:
50 mg

Form: Injection

Reference Brands: Fludara (US/EU)

View Details
Etoposide

Strength:
100 mg

Form: Injection

Reference Brands: Vepesid, Toposar (US)

View Details
Flutamide

Strength:
125mg, 250mg

Form: Tablets / Capsules

Reference Brands: Eulexin (USA/EU), Cytomid (EU)

View Details
Pazopanib

Strength:
200mg, 400mg

Form: Tablets

Reference Brands: Votrient

View Details
Decitabine

Strength:
5mg/ml

Form: Injection

Reference Brands: Dacogen (USA)

View Details
Triptorelin

Strength:
3.75 mg, 11.25 mg, 22.5 mg,

Form: Injection

Reference Brands: Trelstar (USA), Triptodur (USA), Gonapeptyl (EU / UK)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.